PharmaBoardroom

Ulf Claesson provides a fascinating and passionate account of how his firm is aiming to remove ‘guesswork’ and estimations for medical practices…

Frederic Bengold, MD of Servier Switzerland, on the affiliate’s main growth drivers, an exciting collaboration with Novartis on heart failure…

The CEO of Max Zeller, a Swiss Phytopharmaceutical company, highlights the immense benefits his products have and furthermore discusses the…

Santen’s Head of EMEA explains why the company established their new regional headquarters in Geneva, Switzerland and highlights the three key…

How would you present the strengths of the Lake Geneva region’s strengths to our international audience? The Lake Geneva region, which we often…

The CEO of Siemens’ Healthineers Switzerland explains the reasons behind the spinoff of the former Siemens AG segment and elaborates how the…

The general manager of ResMed’s Swiss affiliate explains the company’s efforts to raise the awareness of sleep apnea in the country, and…

Nasri Nahas, CEO of Biopôle in Switzerland, discusses his motivations for joining the biotech, and his mission to re-position the organization as a…

The Chairman of Ferring’s Group Operating Committee and Senior Vice President Europe-Canada elaborates on how Europe can be the thinking engine for…

An expert in the implementation of Swiss federal laws within Switzerland’s constituent cantons, Giovan Maria Zanini discusses the evolution of Swiss…

Switzerland may have a world class healthcare system, but small adjustments are needed to ensure incentives for payer and providers are properly…

Advances in delivery technology and manufacturing costs have driven a surge of activity in peptide drug development, says Thomas Früh, CEO of Bachem…